As new biotech and pharmaceutical companies develop and test their own formulations of psychedelic drugs for therapeutic use, the race for psychedelic patents is heating up — and it could radically shift who holds power in the psychedelic space. But what exactly is happening in the world of psychedelics and intellectual property is still largely secret; US patent applications are sealed for 18 months after submission. Graham Pechenik, a patent attorney and founder of cannabis and psychedelics intellectual property firm Calyx Law, has been keeping a close eye on every patent development, and thinks there could be hundreds of patent applications in the queue.
